Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
DNA and Cell Biology|June 28, 2022
Association Between Circulating Cell-Free DNA Level at Admission and the Risk of Heart Failure Incidence in Acute Myocardial Infarction PatientsQinghai Zhang, Xin He, Jing Ling, et al.
BMC Cardiovascular Disorders|October 22, 2021
Human epididymis protein 4: a novel predictor of ischemic cardiomyopathyYi Tang, Yinzhen Wang, Xiaoping Xu, et al.
Journal of Biochemical and Molecular Toxicology|December 3, 2021
Ginsenoside-Rg1 attenuates sepsis-induced cardiac dysfunction by modulating mitochondrial damage via the P2X7 receptor-mediated Akt/GSK-3β signaling pathwayZhengyu Liu, Hongwei Pan, Yixiong Zhang, et al.
Cardiovascular Drugs and Therapy|May 13, 2020
Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection FractionYajun Gui, Jingyuan Chen, Jiahui Hu, et al.
Journal of Translational Internal Medicine|March 25, 2024
Factors associated with the delay in informed consent procedures of patients with ST-segment elevation myocardial infarction and its influence on door-to-balloon time: a nationwide retrospective cohort studyMailikezhati Maimaitiming, Junxiong Ma, Xuejie Dong, et al.
Cellular Signalling|October 24, 2019
Long non-coding RNA KCNQ1OT1/microRNA-204-5p/LGALS3 axis regulates myocardial ischemia/reperfusion injury in miceJingjing Rong, Hongwei Pan, Jin He, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 13, 2019
Emerging protective roles of shengmai injection in septic cardiomyopathy in mice by inducing myocardial mitochondrial autophagy via caspase-3/Beclin-1 axisYan Cao, Xiaotong Han, Hongwei Pan, et al.
JAMA Network Open|February 10, 2023
Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome: The H-REPLACE Randomized Equivalence and Noninferiority TrialShenghua Zhou, Yichao Xiao, Chonglun Zhou, et al.
ESC Heart Failure|October 13, 2022
Clinical performance and quality measures for heart failure management in China: the China-Heart Failure registry studyYuhui Zhang, Chuanyu Gao, Stephen J Greene, et al.
Pageof 3